Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
The AAPS Journal|April 6, 2006
Simultaneous population optimal design for pharmacokinetic-pharmacodynamic experimentsAndrew Hooker, Paolo ViciniComputer Methods and Programs in Biomedicine|March 3, 2004
POPED, a software for optimal experiment design in population kineticsMarco Foracchia, Andrew Hooker, Paolo Vicini, et al.The Journal of Pharmacy and Pharmacology|December 1, 2022
The manufacturing of 3D-printed microfluidic chips to analyse the effect upon particle size during the synthesis of lipid nanoparticlesEdward Weaver, Essyrose Mathew, Jay Caldwell, et al.Drug Delivery and Translational Research|July 28, 2023
Microfluidic encapsulation of enzymes and steroids within solid lipid nanoparticlesEdward Weaver, Federica Sommonte, Andrew Hooker, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 4, 2011
Optimal experimental design for assessment of enzyme kinetics in a drug discovery screening environmentErik Sjögren, Joakim Nyberg, Mats O Magnusson, et al.Circulation|February 20, 2003
Quantitative magnetic resonance imaging analysis of neovasculature volume in carotid atherosclerotic plaqueWilliam Kerwin, Andrew Hooker, Mary Spilker, et al.International Journal of Pharmaceutics|December 10, 2021
Microfluidic-mediated self-assembly of phospholipids for the delivery of biologic moleculesEdward Weaver, Edward O'Connor, David K Cole, et al.Journal of the American Chemical Society|December 19, 2024
Synthetic T-Cell Receptor-like Protein Behaves as a Janus Particle in SolutionEmily Sakamoto-Rablah, Jordan Bye, Arghya Modak, et al.British Journal of Clinical Pharmacology|September 16, 2010
Plasma and cerebrospinal fluid pharmacokinetics of flurbiprofen in childrenElina Kumpulainen, Pyry Välitalo, Merja Kokki, et al.Journal of Pharmaceutical Sciences|April 4, 2008
Pharmacokinetics of P-glycoprotein inhibition in the rat blood-brain barrierStina Syvänen, Andrew Hooker, Obaidur Rahman, et al.Pageof 2